Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.
FeaturedThe Kerala High Court interpreted Section 100 of the Patents Act, allowing government use of patented inventions for public health. The ruling balances access to medicine with patent rights, emphasizing statutory safeguards.
FeaturedOrissa High Court issues notice on a petition challenging the constitutional validity of Section 147A of the Income Tax Act, with reassessment proceedings stayed per Supreme Court order.
FeaturedA PIL before the Supreme Court seeks formation of an independent expert committee, led by a former CJI or apex court judge, to evaluate structural issues in the Election Commission of India’s functioning. The petition also urges a ban on religiously tagged election campaigning.
FeaturedThe Kerala High Court upheld government use of Novartis's patented cancer drug Ribociclib under Section 100 of the Patents Act for public health purposes, prioritizing access over patent exclusivity in emergencies. The decision balances TRIPS flexibilities with domestic public interest.
FeaturedThe Reserve Bank of India has directed all regulated entities to implement updates to the UNSC 1267/1989 sanctions list under Section 51A of the UAPA, 1967. Three entries in the ISIL (Da'esh) & Al-Qaida sanctions list have been amended, requiring immediate alignment by banks and financial institutions. Non-compliance may attract penal action under anti-terrorism financing laws.
FeaturedSupreme Court stays investigation against Pinarayi Vijayan in the CMRL-Exalogic case for one week, allowing him to challenge FIR registration at Kerala HC.
FeaturedThe Kerala High Court addressed government use of a patented cancer drug, Ribociclib, under Section 100 of the Patents Act, balancing access to medicine against patent rights. The ruling underscores tensions between public health policy and IP enforcement.
FeaturedThe Kerala High Court interpreted Section 100 of the Patents Act in a government use case involving the drug Ribociclib, balancing access to medicine with patent rights. The decision underscores tensions between public health policy, drug pricing, and patent enforcement.
FeaturedA Kerala High Court judgment on government use of patented invention under Section 100 of the Patents Act, 1970 reignites debate on access to medicine, pricing, and policy balance in the context of the drug Ribociclib.
FeaturedThe Kerala High Court addressed the scope of Section 100 of the Patents Act, 1970, in the context of access to the cancer drug ribociclib. The ruling balances public health interests against patent rights, emphasizing lawful government use for public welfare.
FeaturedSC reprimands Chhattisgarh HC for misapplying criminal law in reducing murder conviction to culpable homicide.
FeaturedSupreme Court mandates that fees for entire professional courses be notified in advance and not altered except in exceptional cases.